Momenta whacks top execs, 110 jobs in restructuring; Genentech gains $62M in R&D backing from BARDA
→ Momenta Pharmaceuticals $MNTA is restructuring, booting 110 jobs and a slate of execs in search of some deep budget cuts. As part of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
